Company Profile
Company Name | Japan Hemotech Co., Ltd. |
CEO | Hasegawa Hyo |
Date of Establishment | August 2019 |
Capital | 593,502,873yen (Including capital reserve) |
Bank | Mizuho Bank Shonan Shinkin Bank |
Industry | E-2741 Medical equipment manufacturing industry First class medical equipment manufacturing sales business permission(Permission number:14B1X10038) Medical device manufacturing industry registration (registration number:13BZ201856) |
Corporate philosophy
By providing blood adsorbers that remove unnecessary harmful substances from the blood, our company aims to work towards a society where anyone can receive safe, affordable apheresis treatment anywhere and at any time.
Management message
In the treatment of rare diseases where conventional medications and therapies alone do not yield sufficient effects, apheresis therapy is an expected new treatment approach.
Pharmaceuticals work by an “addition” approach, administering drugs to the body to achieve the desired therapeutic effect. In contrast, apheresis treatment takes a “subtraction” approach by removing unwanted or unnecessary substances from the patient’s blood extracorporeally (outside the body), and then returning the purified blood back into the body. This unique method of treatment can be considered a “cure for subtraction” as it involves removing harmful elements from the bloodstream to improve the patient’s condition.
However, apheresis therapy is not yet widely recognized, so active efforts are needed from doctors and patients to promote awareness, adoption, and technical support.
We aim to fulfill the hopes of many patients through apheresis therapy. We strive to promote the widespread adoption of this treatment method and expand access to opportunities for apheresis therapy, with the ultimate goal of creating a society where anyone, anytime, and anywhere can receive safe and affordable apheresis treatment.
The name of Japan HemoTech Corporation is derived from the abbreviation of “Japan Hemo Technology.” The company name reflects our desire to be a company that continues to contribute to apheresis medicine globally by disseminating blood purification technology from Japan to the world.
Board of Directors
CEO | Hasegawa Hyo |
Executive vice-president | Akasu Hiroyuki |
Director | Ge Kan |
Auditor | Kawashima Norimichi |
Company History
August 2019 | Establishment of Japan Hemotech Co., Ltd. CEO Hasegawa Hyo |
January 2020 | Opening of Yokohama Sales office Yokohama TH Building 813, 1-2 Chitose-cho, Naka-ku, Yokohama-shi, Kanagawa |
February 2020 | Capital increase: New capital 10,415,000 yen |
March 2020 | Relocation of Main office NANOBIC2007 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki-shi, Kanagawa |
December 2020 | Capital increase: New capital 87,005,390 yen |
September 2021 | Establishment of Yokohama Research Institute Yokohama Bio Industry Center 126, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama-shi, Kanagawa |
August 2022 | Relocation of Yokohama Sales office Yokohama TH Building 811, 1-2 Chitose-cho, Naka-ku, Yokohama-shi, Kanagawa |
October 2022 | Opening of Tokyo Factory 2-30-10 Hyoe, Hachioji-shi, Tokyo |
December 2022 | Capital increase: New capital 563,502,873 yen |
July 2023 | Capital/capital reserves 293,502,873 yen |
December 2023 | Closure of Yokohama Sales Office |
December 2023 | Opening of Kawasaki Sales office KBIC117 7-7Sin-Kawasaki,Saiwai-ku,Kawasaki-shi,Kanagawa |
February 2024 | Obtained Certification for Manufacturing and Sales of Class I Medical Devices |
March 2024 | Registered as a Kawasaki SDGs Partner business |
June 2024 | Registered Medical Device Manufacturer at Tokyo Factory |
July 2024 | Capital/capital reserves 593,502,873 yen |
Company Locations
Main office
〒212-0032
NANOBIC2007 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki-shi, Kanagawa
Phone: 044-223-8980
Access to Main office
By train
・JR Yokosuka Line ➔
alight at Shin-Kawasaki Station,
10 minutes on foot
・JR Nambu Line ➔
alight at Kashimada Station,
15 minutes on foot
Yokohama Research Institute
〒230-0045
Yokohama Bio Industry Center 126, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama-shi, Kanagawa
Phone: 045-642-3831
Access to Yokohama Research Institute
By train
・JR Tsurumi Line ➔
alight at Tsurumi-Ono Station,
15 minutes on foot
By Bus (Duration: 12-15 minutes)
1) JR Keihin-Tohoku Line ➔
Keikyu Line ➔
alight at Tsurumi Station,
exit via East Exit for bus terminal
alight at Keikyu Tsurumi Station,
exit via West Exit for bus terminal
2) Kawasaki Tsurumi-Rinko bus terminal: Tsuru 08 Line from Gate 8 (Bound for Fureyu)
➔ alight at RIKEN City University Graduate School Stataion,
3 minutes on foot
Tokyo Factory
〒192-0918
2-30-10 Hyoe, Hachioji-shi, Tokyo
Phone: 042-683-1520
Access to Tokyo Factory
By train
・JR Yokohama Line ➔
alight at Hachioji Minamino Station,
15 minutes on foot
Kawasaki Sales Office
〒231-0035
KBIC117 7-7 Sin-Kawasaki, Saiwai-ku, Kawasaki-shi,
Kanagawa
Phone: 044-589-7390
Access to Kawasaki Sales office
By train
・JR Yokosuka Line ➔
alight at Shin-Kawasaki Station,
10 minutes on foot
・JR Nambu Line ➔
alight at Kashimada Station,
15 minutes on foot